GSHD earnings analysis
What we found in GSHD's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Goosehead delivered Q2 revenue of $113.389 million, up 20.6% year over year and 21.9% sequentially based on the provided quarterly history, while GAAP diluted EPS increased to $0.41 from $0.18 a year earlier. Adjusted EBITDA rose 30% to $37.948 million and written premium grew 14% to $1.335 billion. Management raised its organic revenue-growth outlook to 12%-19%, although the filing excerpt does not provide segment, detailed balance-sheet, operating-margin, or cash-flow figures needed to assess working-capital and free-cash-flow trends.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue accelerated above $113 million
- Q2 revenue was $113.389 million, up $19.389 million, or 20.6%, from $94 million in 2025Q2 and up $20.389 million, or 21.9%, from $93 million in 2026Q1.
- EPS improved sharply year over year
- Diluted GAAP EPS was $0.41, versus $0.18 in 2025Q2 and $0.19 in 2026Q1. Separately, reported adjusted EPS was $0.64 versus the $0.47 consensus estimate.
- Profit and premium growth remained strong
- Adjusted EBITDA grew 30% year over year to $37.948 million, while written premium increased 14% to $1.335 billion.
- Organic revenue outlook raised
- The company raised its 2026 organic revenue-growth outlook to 12%-19% from 10%-19%, while retaining its 12%-20% written-premium-growth outlook.
- Large repurchase capacity remains
- The board extended and increased the Class A repurchase authorization to $198.3 million through May 1, 2027. At June 30, 2026, $144.568 million remained available after 95 thousand shares were repurchased at an average $40.95 per share.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No material risk-factor updates
- The filing states that there were no material changes to risk factors disclosed in the 2025 Form 10-K. Investors therefore receive no updated, filing-specific quantification of operating risks as of June 30, 2026.
- Written-premium outlook remains broad
- Management maintained written-premium-growth guidance at 12%-20%, despite raising organic revenue-growth guidance to 12%-19%; the unchanged premium range leaves a wide 8-percentage-point execution range for the remainder of 2026.
- GAAP-to-adjusted EPS gap persists
- Reported GAAP diluted EPS of $0.41 was below the separately reported adjusted EPS of $0.64, a $0.23 difference that indicates non-adjusted charges or expenses remain relevant to statutory profitability.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.41
- Gross margin
- 100.0%
What they said about what is next.
Management raised full-year 2026 organic total-revenue-growth outlook to 12%-19% from 10%-19%. Total written-premium-growth outlook was maintained at 12%-20%; the 10-Q does not provide dollar revenue or EPS guidance ranges.
The filing reads better than the one before it.
What came before.
- 10-Q · April 23, 2026
- Goosehead reported Q1 2026 total revenue of $93,076,000 and adjusted EPS of $0.37, delivering a clear beat to consensus. Management highlighted core revenue of $79.5 million (+15% YoY) and Adjusted EBITDA of $24.4…
- 10-K · February 19, 2026
- Goosehead presents a growth-focused, tech-enabled franchise and corporate distribution model for personal lines insurance, emphasizing scale, agent productivity and a proprietary quoting platform. Total Written Premium…
- 10-Q · April 28, 2023
- Goosehead reported quarterly revenue of $57,955,000 (up from $41,278,000 in Q1 2022, +$16,677,000 or +40.4%). The company swung to income from operations of $1,469,000 versus an operating loss of $6,102,000 a year…
- 10-Q · April 28, 2022
- Goosehead reported Q1 revenue of $41,278 (in thousands) versus $31,228 in Q1 2021, driven by franchise revenue growth. Operating loss widened to $(6,102) (in thousands) and GAAP diluted EPS declined to $(0.11) from…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing GSHD makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever